Chłoniak folikularny u psa. Opis przypadku

• Autorzy: Pawlak A. , Krupa A. , Hildebrand W. , Pozniak B. , Dzimira S.

Warianty tytułu

EN

Follicular lymphoma in a dog. Case report

• Języki publikacji: PL

Abstrakty

EN

Lymphoma is the most common hematopoetic neoplasm in dogs. It constitutes a heterogeneous group of cancers derived from lymphocytes at different stages of maturation. Follicular lymphoma is a low-grade cancer with benign clinical behavior, which arises from the neoplastic transformation and subsequent proliferation of B lymphocytes. This report describes a clinical case of follicular lymphoma diagnosed in a 6-year-old female Dalmatian. Diagnostic workup revealed an enlargement of the right submandibular lymph node without abnormalities in peripheral blood morphology and biochemistry, abdominal ultrasonography and thoracic radiography. The enlarged lymph node was surgically removed for histological and immunohistochemical evaluation. To determine the immunophenotype of neoplastic cells, flow cytometry analysis was carried out. On the basis of clinical and laboratory findings, follicular lymphoma stage I a (WHO classification) was diagnosed.

Słowa kluczowe

PL

psy; choroby zwierzat; nowotwory; chloniak grudkowy; diagnostyka; leczenie

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2012
• Tom: 68
• Numer: 09
• Opis fizyczny: s.571-574.fot.,bibliogr.

Twórcy

autor

Pawlak A.

• Zakład Farmakologii i Toksykologii, Katedra Biochemii, Farmakologii i Toksykologii, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy we Wrocławiu, ul.Norwida 31, 50-375 Wrocław

autor

Krupa A.

autor

Hildebrand W.

autor

Pozniak B.

autor

Dzimira S.

Bibliografia

• 1. Benandi M.: Aiming at a Curative Strategy for Follicular Lymphoma. CA Cancer J. Clin. 2008, 58, 305-317.
• 2. Boyce K. L., Kitchell B. E.: Treatment of canine lymphoma with COPLA/LVP. J. Am. Anim. Hosp. Assoc. 2000, 36, 395-403.
• 3. Culmsee K., Simon D., Mischke R., Nolte I.: Possibilities of flow cytometric analysis for immunophenotypic charakterization of canine lymphoma. J. Vet. Med. Ser. A. 2001, 48, 199-206.
• 4. Fredrickson T. N., Lennert K., Chattopadhyay S. K., Morse H. C. III, Hartley J. W.: Splenic marginal zone lymphomas of mice. Am. J. Pathol. 1999, 154, 805-812.
• 5. Gauthier M. J., Aubert I., Abrams-Ogg A., Woods J. P., Bienzle B.: The immunophenotype of Peripheral Blood Lymphocytes in Clinically Healthy Dogs and Dogs with Lymphoma in Remission. J. Vet. Int. Med. 2005, 19, 2, 193-199.
• 6. Hahn K. A., Richardson R. C., Hahn E. A., Chrisman C. L.: Diagnostic and prognostic importance of chromosomal aberration identified in 61 dogs with lymphosarcoma. Vet. Pathol. 1994, 31, 528-540.
• 7. Mack G. S.: Cancers research ushers in dog days medicine. Nat. Med. 2005, 11, 1018.
• 8. Marin G. H., Dal Cortivo L., Cayuela J. M., Marolleau J. P., Pautier P., Cojean-Zelek I., Brice P., Makke J., Benbunan M., Gisselbrecht C.: Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphoma. Hematol. Cell. Ther. 1997, 39, 33-40.
• 9. Rassnick K. M., Mauldin G. E., Al-Sarraf R., Mauldin G. N., Moore A. S., Mooney S. C.: MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000). J. Vet. Intern. Med. 2002, 16, 576-580.
• 10. Sozmen M., Tasca S., Carli E., De Lorenzi D., Furlanello T., Caldin M.: Use of fine needle aspirates and flow cytometry for the diagnosis, classification and immunophenotyping of canine lymphomas. J. Vet. Diagn. Invest. 2005, 17, 323-329.
• 11. Vail D. M., MacEwen E. G.: Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 2000, 18, 781-792.
• 12. Valli V. E., Vernau W., de Lorimieri L.-P. Graham P. S., Moore P. F.: Canine Indolent Nodular Lymphoma. Vet. Pathol. 2006, 43, 241-256.
• 13. Wilkerson M. J., Dolce K., Koopman T., Shuman W., Chun R., Garrett L., Barber L., Avery A.: Lineage differentiation of canine lymphoma/leukemia and aberrant expression of CD molecules. Vet. Immunol. Immunopathol. 2005, 106, 179-196.